Growth Metrics

Nuwellis (NUWE) Debt to Equity (2015 - 2016)

Nuwellis posted quarterly Debt to Equity of $1.07 for Q2 2016, up 1281.49% year-on-year from $0.08 in Q3 2015, and up 110.13% on a QoQ basis from $0.51 in Q1 2016.

Nuwellis (NUWE) has 2 years of Debt to Equity data on file, last reported at $1.07 in Q2 2016.

  • For the quarter ending Q2 2016, Debt to Equity rose 1281.49% year-over-year to $1.07; the trailing twelve-month figure through Jun 2016 stood at $1.07 (up 1281.49% YoY), and the FY2015 full-year result was $0.31, changed N/A from the prior year.
  • Debt to Equity for Q2 2016 stood at $1.07, up from $0.51 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.07 in Q2 2016 and bottomed at $0.02 in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2016 1.07
Mar 31, 2016 0.51
Dec 31, 2015 0.31
Sep 30, 2015 0.16
Jun 30, 2015 0.08
Mar 31, 2015 0.02